Lakewood-Amedex Biotherapeutics Inc. (LABT) Cash flow

21 Followers

Lakewood-Amedex Biotherapeutics Inc. Cash Flow

LABT's free cash flow for Q2 2026 was $-2.10M. For the 2026 fiscal year, LABT's free cash flow was decreased by $― and operating cash flow was $-2.10M. See a summary of the company’s cash flow.

Cash Flow	Dec 25
Operating Cash Flow	$ -1.94M
Investing Cash Flow	$ 0.00
Financing Cash Flow	$ 1.50M
End Cash Position	$ 236.40K
Free Cash Flow	$ -1.94M

Currency in USD